Caribou Biosciences, Inc. (CRBU) Deferred Tax Assets, Valuation Allowance USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Caribou Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2020 to 2023.
  • Caribou Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $96.2 M, a 44.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $96.2 M +$29.8 M +44.8% Dec 31, 2023 10-K 2024-03-11
Q4 2022 $66.4 M +$31.9 M +92.4% Dec 31, 2022 10-K 2024-03-11
Q4 2021 $34.5 M +$23.8 M +223% Dec 31, 2021 10-K 2024-03-11
Q4 2020 $10.7 M Dec 31, 2020 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.